Abstract
The aim of this chapter is to outline the specific issues encountered in designing and analysing data from clinical trials on the antiemetic efficacy and tolerability of therapies in cancer patients receiving chemotherapy. This is necessary not only to obtain optimal control of systematic errors, but also to describe their influence on the statistical analysis of the responses.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Tonato M, Roila F, Del Favero A: Methodology of antiemetic trials: a review. Ann Oncol 1991 (2): 107–114
Del Favero A, Roila F, Basurto C et al: Assessment of nausea. Eur J Clin Pharmacol 1991 (38):115–120
Chevallier B, on behalf of the Granisetron Study Group: The control of acute cisplatin-induced emesis. A comparative study of granisetron and a combination regimen of high-dose metoclopramide and dexamethasone. Br J Cancer 1993 (68):176–180
Soukop M on behalf of the Granisetron Study Group: A dose-finding study of granisetron, a novel antiemetic, in patients receiving high-dose cisplatin. Support Care Cancer 1994 (2): 177–183
Roila F, Tonato M, Cognetti F et al: Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone. J Clin Oncol 1991 (9):675–678
Smyth F, Coleran RE, Nicholson M et al: Does dexamethasone enhance control of acute cispaltin induced emesis by ondansetron? Br Med J 1991 (303):1423–1426
Hesketh P, Harvey WH, Harker WG et al: A randomized, double-blind comparison of intravenous ondansetron alone and in combination with intravenous dexamethasone in the prevention of high-dose cisplatin-induced emesis. J Clin Oncol 1994 (12):596–600
Italian Group for Antiemetic Research: Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer. N Engl J Med 1995 (322): 1–5
Roila F, Tonato M, Basurto C et al: Antiemetic activity of high doses of metoclopramide combined with methylprednisolone vs metoclopramide alone in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research. J Clin Oncol 1987 (5):141–149
Pater J, Slamet L, Zee B, Osoba D, Warr D, Rusthoven J: Inconsistency of prognostic factors for both chemotherapy-nausea and vomiting. Support Care Cancer 1994 (2):161–166
Roila F, Tonato M, Basurto C et al: Antiemetic activity of two different high doses of metoclopramide in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research. Cancer Treat Rep 1985 (69): 1353–1357
Roila F, Tonato M, Basurto C et al: Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research. J Clin Oncol 1989 (7):1693–1700
Italian Group for Antiemetic Research: Difference in persistence of two antiemetic regimens on acute emesis during cisplatin chemotherapy. J Clin Oncol 1993(11):2396–2404
Roila F, Tonato M, Del Favero A: Publication of unethical studies on the treatment of chemotherapy-induced emesis (letter to Editor). J Clin Oncol 1991 (9):891–892
Ruff P, Paska W, Goedhals L et al on behalf of the Ondansetron and Granisetron Emesis Study Group: Ondansetron compared with granisetron in the prophylaxis of cisplatin induced acute emesis: a multicenter double-blind, randomized, parallel-group study. Oncology 1994 (51):113–118
Sorbe BG, Hogberg T, Glimelius B et al: A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis. Cancer 1994 (73):445–454
Prescott RJ: The comparison of success rates in cross-over trials in the presence of an order effect. Appl Statistics 1981 (30):9–15
Ballatori E: Modelli logistici nell’analisi di dati binari con misure ripetute. Proceedings of the ‘II Congresso Nazionale dell’Associazione Italiana di Sta-tistica Medica e Programmazione Socio Sanitaria’, Pavia, 26–28 Oct 1989:271–278
Kenward MG and Jones B: A log-linear model for binary cross-over data. Appl Statistics 1987 (36): 192–204
Italian Group for Antiemetic Research: On the relationship between nausea and vomiting in patients undergoing chemotherapy. Support Care Cancer 1994(2):171–176
Italian Group for Antiemetic Research: Cisplatin-induced delayed emesis: pattern and prognostic factors during three subsequent cycles. Ann Oncol 1994(5):585–589
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Ballatori, E., Roila, F., Favero, A.D. (1996). Methodology of Antiemetic Trials. In: Tonato, M. (eds) Antiemetics in the Supportive Care of Cancer Patients. ESO Monographs. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80240-9_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-80240-9_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-80242-3
Online ISBN: 978-3-642-80240-9
eBook Packages: Springer Book Archive